A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
Clinical trial NCT05975060 · COMPLETED
Trial details
- NCT number
- NCT05975060
- Sponsor
- Novavax
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-07
- Primary completion
- 2023-11-15
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.